24,892.66
-239.63
(-0.95%)
8,251.07
-109.61
(-1.31%)
4,668.23
-146.60
(-3.04%)
4,717.24
-21.99
(-0.464%)
14,061.44
-202.85
(-1.422%)
65,815.6100
-740.5400
(-1.113%)
22/01/2025 11:26
大行報告 | 蔚小理、藥明系、電訊股、比亞迪及領展最新評級/目標價,一表盡掌握
.高盛點評蔚小理,降理想(02015)、蔚來(09866)目標卻升小鵬(09868)目標
.高盛調升藥明系目標價,其中藥明康德(02359)目標由58元升至62.4元
.大摩看好中資電訊股,皆維持超配評級



1069,,新聞,專題透視,reports